Design of intelligent algorithms and development of decision-making models to form risk management systems, personalized diagnosis and patient treatment systems, and to process modelling systems.
Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Identification and quantification of proteins and other biomolecules using advanced mass spectrometry methods and discovery of novel drug candidates through integrated bioanalytical services.